期刊文献+

胰岛素样生长因子-1和原发性高血压的关系 被引量:5

Insulin-like growth factor-1 and essential hypertension
下载PDF
导出
摘要 目的探讨血清胰岛素样生长因子-1(insulin-like growth factor,IGF-1)浓度与原发性高血压(高血压)及左心室肥厚(left ventricular hypertrophy,LVH)的关系,为高血压的诊断和治疗提供理论依据和新思路。方法选择高血压患者100例为研究对象,按照高血压分级分为1、2、3级,计算左心室质量指数(left ventricular massindex,LVMI),分为LVH组和无LVH组;另外,选择30名健康体检者作为对照组。分别用放射免疫法测定血清IGF-1浓度。高血压患者降压治疗3个月后测定血压与血清IGF-1浓度,然后进行统计学分析。结果高血压患者血清IGF-1浓度明显高于正常对照组,且高血压1~3级组间血清IGF-1浓度比较,差异有统计学意义[(412.34±41.45)ng/mL vs.(329.41±32.76)ng/mL vs.(257.56±45.32)ng/mL vs.(142.47±41.32)ng/mL,P<0.05]。高血压伴LVH患者血清IGF-1浓度[(387.45±35.76)ng/mL vs.(296.57±40.23)ng/mL,P<0.05]、左心室质量指数[(148.25±18.14)g/m2 vs.(109.43±17.68)g/m2,P<0.05]高于无伴LVH患者,差异有统计学意义。高血压患者血清IGF-1浓度与左心室质量指数呈正相关(r=0.83,P<0.05)。高血压组经药物治疗3个月后血压达标患者的血清IGF-1浓度显著低于血压未达标患者,差异有统计学意义[(259.17±42.64)ng/mL vs.(324.65±37.17)ng/mL,P<0.05]。结论高血压患者血清IGF-1浓度升高,并随着血压水平和病情严重程度更加明显,提示IGF-1在高血压LVH的发生发展过程中发挥重要作用,可能参与高血压LVH的调节。 Objectives To investigate the relationship of IGF-1 with essential hypertension (EH) and left ventricular hypertrophy (LVH) for providing a new method for the diagnosis of EH. Methods One hundred patients with EH were recruited and divided into 3 subgroups of EH 1 to 3. The value of left ventricular mass index (LVMI) of all these cases were evaluated by eehocardiography. Patients were divided into non-LVH group and LVH group by LVMI. Besides, 30 healthy subjects were included as control group. Serum concentration of IGF-1 were measured by radioimmunoassay using nitrate reduetase. Serum concentration of IGF-1 in 100 patients with EH were measured after treatment for 3 months. Statistical analysis was done. Results Serum concentration of IGF-1 in patients with EH was significantly higher than that in control group, and there were significant differences of serum concentrations of IGF-1 among the 3 clinical grading EH groups [ (412.34±41.45)ng/mL vs. (329.4132.76)ng/mL vs. (257.56±45.32)ng/mL vs. ( 142.47 ±41.32)ng/mL, P 〈0.05]. Serum concentration of IGF-1 [ (387.45 ±35.76)ng/mL vs. (296.57 ±40.23)ng/ mL,P〈0.05], LVMI[ ( 148.25±18.14)g/m2 vs. ( 109.43±17.68)g/m2,p〈0.05] in LVH group was significantly higher than that in non-LVH group. Serum concentration of IGF-1 in patients with EH positively correlated with LVMI(r=0.83, P〈0.05 ). After 3 months' treatment, serum concentration of IGF-1 decreased more significantly in patients with normal blood pressure than that in patients with abnormal blood pressure [ ( 259.17 ±42.64) ng/mL vs. ( 324.65 ± 37.17 ) ng/mL, P〈0.05]. Conclusions Serum concentration of IGF- 1 increased in patients with EH, and serum concentration of IGF- 1 closely correlated with the clinical severity of hypertension, indicating that IGF-1 may play an important role in the occurrence and development of LVH.
作者 左奇玉
出处 《岭南心血管病杂志》 2011年第5期390-392,397,共4页 South China Journal of Cardiovascular Diseases
关键词 高血压 胰岛素样生长因子-1 左心室肥厚 essential hypertension insulin-like growth factor- 1 left ventricular hypertrophy
  • 相关文献

参考文献5

二级参考文献16

  • 1Van EM, Vetter H, Grohe C. Angiotensin-converting enzyme inhibitor(ACE) inhibition attenuates insulin-like growth factorI (IGF-Ⅰ) induced cardiac fibroblast proliferation [J ]. British Journal of Pharmacology,2000,131: 1592-1596.
  • 2Marijke B, Jacqueline CS, Russ P, et al. Angiotensin Ⅱ stimulates gene expression of cardiac insulin-like growth factor-1 and its receptor through effects on blood pressure and food intake [J]. Hypertension, 1999,34:1053-1059.
  • 3LeRoith D, Werner H, Beither-Johmson D, et al. Molecular and cellular aspects of the insulin-like growth factor-1 receptor [J]. Endocr Rev,1995,16:143-163.
  • 4Patrick D, Marjike B, Jie Du. Angiotensin Ⅱ modulation insulin-like growth factor-1 expression in the cardiovascular system [J]. Thrend Cardiovasc Med,1996,6:187-196.
  • 5Haddad GE, Blackwell E, BikhaziA. Regulation of insulin-like growth factor-1 by the rennin-angiotensin system during regression of cardiar eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist[J]. Can J Physiol Pharmarol, 2003,81 : 142-149.
  • 6Delafontaine P, Brink M. The hormone and insulin-like growth factor-1 axis in heart failure [J]. Endoerinol (Paris), 2000,61:22-26.
  • 7Donohue TJ, Dworkin LD, Ma J, et al. Antihypertensive agents that limited ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-1[J]. J Invest Med, 1997,45:584-591.
  • 8Valerie R, Christophe H, Jean-Sebastien S, et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone[J]. Hypertension, 1999,33: 981-986.
  • 9Pietro AM, Simone V, Iacopo B, et al. Early sequence of cardiac adaptation and growth factor formation in pressure and volume-overload hypertrophy[J]. Am J Physiol Heart Circ Physiol,2000,279: 976-985.
  • 10Clemmons DR, Moses AC, Mckay MJ, et al. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity[J]. Clin Endocrinol Metab, 2000,85 : 1518-1524.

共引文献16

同被引文献56

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部